Skip to main content
. Author manuscript; available in PMC: 2023 Mar 7.
Published in final edited form as: FEBS J. 2021 May 24;289(5):1315–1328. doi: 10.1111/febs.15963

Figure 1. Histone mutations in cancers.

Figure 1.

Schematic of the histone H3.3 tail above, highlighting key residues (K27, G34, K36) recurrently mutated in cancers and their associated post-translational modifications. Depicted below is the regional tissue specificity of oncohistone mutations and their occurrence in specific cancer types.